These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25158008)

  • 1. Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART.
    Arentzen M; Jubt F; Evers S; Hesselmann V; Fiori W; Reichelt D; Oelker-Grueneberg U; Schwindt W; Dziewas R; Husstedt IW
    Int J Neurosci; 2015; 125(8):601-11. PubMed ID: 25158008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.
    Rasmussen LD; Engsig FN; Christensen H; Gerstoft J; Kronborg G; Pedersen C; Obel N
    AIDS; 2011 Aug; 25(13):1637-46. PubMed ID: 21646903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemic cerebrovascular events in HIV infection: a cohort study.
    Evers S; Nabavi D; Rahmann A; Heese C; Reichelt D; Husstedt IW
    Cerebrovasc Dis; 2003; 15(3):199-205. PubMed ID: 12646780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
    Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
    Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.
    Piketty C; Selinger-Leneman H; Bouvier AM; Belot A; Mary-Krause M; Duvivier C; Bonmarchand M; Abramowitz L; Costagliola D; Grabar S
    J Clin Oncol; 2012 Dec; 30(35):4360-6. PubMed ID: 23091098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
    Mocroft A; Phillips AN; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren JD;
    Lancet; 2007 Aug; 370(9585):407-13. PubMed ID: 17659333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
    Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
    AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort.
    Pacheco YM; Jarrin I; Rosado I; Campins AA; Berenguer J; Iribarren JA; Rivero M; Muñoz-Medina L; Bernal-Morell E; Gutiérrez F; Leal M;
    Antiviral Res; 2015 May; 117():69-74. PubMed ID: 25766861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and Risk Factors for Cerebral Arterial Disease in a HIV/AIDS Neuroimaging Cohort.
    Edwards NJ; Grill MF; Choi HA; Ko NU
    Cerebrovasc Dis; 2016; 41(3-4):170-6. PubMed ID: 26751784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
    de Monteynard LA; Dray-Spira R; de Truchis P; Grabar S; Launay O; Meynard JL; Khuong-Josses MA; Gilquin J; Rey D; Simon A; Pavie J; Mahamat A; Matheron S; Costagliola D; Abgrall S;
    PLoS One; 2015; 10(3):e0118492. PubMed ID: 25734445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
    Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
    Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States.
    Vinikoor MJ; Napravnik S; Floris-Moore M; Wilson S; Huang DY; Eron JJ
    AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1068-74. PubMed ID: 23565888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
    Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy.
    Gkentzi D; Tebruegge M; Tudor-Williams G; Walters S; Lyall H; Sharland M; Doerholt K
    Pediatr Infect Dis J; 2014 Sep; 33(9):953-8. PubMed ID: 24618936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort.
    Hleyhel M; Hleyhel M; Bouvier AM; Belot A; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Spano JP; Costagliola D; Grabar S;
    AIDS; 2014 Sep; 28(14):2109-18. PubMed ID: 25265077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
    Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
    J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.